Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Pepmic is a specialized biotechnology company focused on the custom synthesis and manufacturing of high-quality peptides for research and pharmaceutical applications. Based in Suzhou, China, the company provides a comprehensive range of services including custom peptide synthesis, peptide library construction, and large-scale GMP manufacturing. Pepmic supports drug discovery and development through its expertise in complex peptide modifications, such as phosphorylation, methylation, and the creation of peptide-drug conjugates. Their facilities are equipped for both small-scale R&D and commercial-grade production, serving a global clientele in the life sciences industry. The company also offers integrated solutions in antibody development, recombinant protein expression, and gene synthesis.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Pepmic.